Validation of SaaS / Cloud-Hosted GxP Systems & Infrastructure
Data Residency, Privacy and GxP Compliance in Cloud Deployments Data Residency, Privacy and GxP Compliance in Cloud Deployments In the evolving landscape of the pharmaceutical industry, data residency and privacy are integral to compliance with Good Practice (GxP) regulations. As organizations increasingly migrate towards cloud-based solutions for data management, understanding the regulatory expectations surrounding data residency, privacy, and protection becomes…
Vendor Assessment and Audits for SaaS GxP Providers Vendor Assessment and Audits for SaaS GxP Providers In the highly regulated pharmaceutical industry, maintaining compliance and ensuring the reliability of software systems are paramount, especially when adopting third-party services. As Software as a Service (SaaS) solutions gain traction, particularly for Good Automated Manufacturing Practice (GxP) critical operations, vendors must undergo thorough…
Qualifying Cloud Infrastructure IaaS and PaaS for GxP Use In the evolving landscape of the pharmaceutical industry, the adoption of cloud computing technology, including Infrastructure as a Service (IaaS) and Platform as a Service (PaaS), has transformed how organizations manage their IT resources. The regulatory environment in which pharmaceutical companies operate is stringent, with clear guidelines set forth by agencies…
Cloud Computer System Validation Strategy for SaaS GxP Applications Introduction to Cloud Computer System Validation in the Pharmaceutical Industry The advent of cloud computing has transformed numerous industries, including pharmaceuticals. This transformation has led to the rise of Software as a Service (SaaS) applications that facilitate compliance with Good Manufacturing Practices (GMP). Understanding the regulatory expectations surrounding computer system validation…
Cloud Security Controls for GxP Data Integrity and Regulatory Compliance Introduction to Cloud Security in GxP Environments The adoption of cloud computing in regulated environments has significantly transformed data management paradigms in the pharmaceutical and life sciences industries. The conformance of cloud-hosted systems to Good Practice (GxP) guidelines is critical, as any compromise may jeopardize data integrity and regulatory compliance….
GxP Validation of Data Integration Platforms and APIs in the Cloud The increasing adoption of cloud technology in the pharmaceutical sector necessitates robust validation practices for data integration platforms and APIs. This article provides a comprehensive overview of regulatory expectations and best practices for the validation of cloud APIs, particularly in Good Automated Manufacturing Practice (GxP) environments. Our focus will…
Validating Identity and Access Management in Cloud Hosted GxP Environments Validating Identity and Access Management in Cloud Hosted GxP Environments In the era of digitization, the integration of cloud technologies in Good Automated Manufacturing Practice (GxP) environments has transformed how pharmaceutical organizations manage their operations. A crucial element of this transformation is Identity and Access Management (IAM). This article provides…
Disaster Recovery and Business Continuity Planning for Cloud GxP Systems Disaster Recovery and Business Continuity Planning for Cloud GxP Systems Introduction to DR and BCP for Cloud GxP Disaster Recovery (DR) and Business Continuity Planning (BCP) are critical components within the pharmaceutical industry to ensure the continued integrity and availability of Good Practice (GxP) systems. As regulatory frameworks become increasingly…
Change Management and Release Validation for Multi-tenant SaaS Platforms In the evolving landscape of pharmaceutical regulations and technological advancements, the validation of multi-tenant Software as a Service (SaaS) platforms has gained significant attention. Regulatory expectations from organizations such as the US FDA, EMA, and PIC/S require robust validation frameworks that encompass change management and release validation processes. This document serves…
Managing GxP Responsibilities Between Sponsor and Cloud Provider The rise of cloud computing in the pharmaceutical sector has significantly transformed the landscape of Good Automated Manufacturing Practice (GxP) compliance, necessitating clear delineation of responsibilities between sponsors and cloud providers. This article provides a thorough examination of regulatory expectations, mainly based on US FDA guidelines, EMA Annex 15, and other relevant…